Hidradenitis Suppurativa [2026]: Causes, Triggers, and Prescription Treatment Options
Disclosure: This page contains affiliate links. If you purchase through our links, we may earn a commission at no extra cost to you. Our editorial opinions are our own.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful, recurrent nodules, deep abscesses, and draining tunnels in intertriginous skin folds like the underarms and groin. Driven by follicular occlusion and immune dysregulation rather than hygiene or infection, early diagnosis and prescription therapies—including topical clindamycin, oral antibiotics, spironolactone, and targeted biologics—are essential to preventing irreversible scarring.
Affiliate Disclosure: PrescribedGlow is supported by our readers. When you purchase prescription treatments through links on our site, we may earn an affiliate commission at no extra cost to you.
What is the difference between hidradenitis suppurativa and boils or acne?
Hidradenitis suppurativa differs from simple boils and acne vulgaris because it is a chronic, progressive follicular disease rather than an isolated staphylococcal infection or cosmetic breakout. While boils resolve permanently after draining and acne develops primarily on the face and upper back, HS recurs predictably in intertriginous friction zones, forming underground tunnels and fibrotic scars.
Because early hidradenitis lesions present as tender, inflammatory bumps, they are frequently misidentified as simple ingrown hairs, standard furuncles (boils), or deep cystic acne. However, their anatomical distribution, internal pathophysiology, and long-term prognosis differ markedly:
| Clinical Feature | Hidradenitis Suppurativa | Furuncle (Boil) | Acne Vulgaris |
|---|---|---|---|
| Primary Mechanism | Follicular occlusion & sterile immune cascade (TNF, IL-17) | Acute bacterial infection (Staphylococcus aureus) | Pore blockage by sebum & C. acnes colonization |
| Common Locations | Axillae, groin, inner thighs, inframammary folds | Random (buttocks, neck, thighs, face) | Face, chest, upper back, shoulders |
| Lesion Characteristics | Painful deep nodules, abscesses, subcutaneous tunnels | Isolated red, fluctuant, pus-filled nodule | Comedones (blackheads/whiteheads), papules, pustules |
| Recurrence Pattern | Chronic recurrence in exact same skin folds | Single episode; rarely recurs in same follicle | Continuous or cyclic generalized breakouts |
| Scarring Pattern | Fibrotic, thick, rope-like keloidal bands | Minimal; superficial post-inflammatory mark | Atrophic pitting or small localized marks |
This diagnostic confusion carries severe consequences. According to a multi-center epidemiological study by Martins et al. published in Skin Appendage Disorders, patients experience a mean diagnostic delay of 10.1 years from initial symptom onset to formal clinical diagnosis (PMID: 38572195).
During this decade-long delay, patients are often told their lesions are merely hygienic failures or minor bouts of folliculitis, allowing chronic inflammation to burrow deeper into underlying dermal architecture.
What causes hidradenitis suppurativa to flare up?
Hidradenitis suppurativa flares are initiated when the upper portion of a hair follicle becomes occluded by abnormal keratin build-up. This traps secretions inside the follicular infundibulum until the follicle wall ruptures beneath the skin, releasing cellular debris that ignites an intense inflammatory response driven by TNF-alpha, IL-17, and IL-1 beta cytokines.
Rather than originating in sweat glands as medical literature historically assumed, HS is fundamentally a disease of the terminal hair follicle unit. When the swollen follicular wall ruptures under mechanical tension, cellular components leak directly into surrounding dermal tissue. The immune system reacts as though confronted with foreign trauma, mounting a massive sterile immune assault characterized by intense neutrophilic infiltration, tissue necrosis, and sinus tract creation.
While follicular occlusion serves as the root mechanical engine, systemic factors dictate disease severity and frequency of flares. According to epidemiological research published in the Journal of the American Academy of Dermatology by Revuz et al. (PMID 37696341), HS in Western populations exhibits a pronounced female predominance, affecting women at approximately three times the rate of men (a 3:1 ratio). Furthermore, clinical surveys indicate that over 60% of affected women experience worsening inflammatory flares immediately preceding menstruation, underscoring the strong influence of cyclic hormonal shifts.
Key triggers that provoke and exacerbate hidradenitis suppurativa flares include:
- Mechanical Friction & Shearing: Skin-on-skin rubbing in the groin, armpits, and under the breasts physically irritates fragile follicular openings, accelerating wall rupture.
- Hormonal Fluctuations: Androgen surges and rapid progestin-estrogen shifts stimulate follicular hyperkeratinization and sebum changes, closely paralleling the mechanisms seen in hormonal acne.
- Metabolic Inflammation & Body Weight: Adipose tissue functions as an active endocrine organ, secreting pro-inflammatory adipokines that magnify baseline immune activation, while skin folds create warm, humid friction environments.
- Tobacco & Nicotine Exposure: Nicotine directly promotes epidermal hyperplasia, thickens follicular infundibula, and stimulates neutrophil chemotaxis, making smoking a primary environmental driver of severe flare activity.
- Chronic Emotional Stress: Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, elevating systemic cortisol and neurogenic inflammatory peptides that trigger acute swelling.
What are the three stages of hidradenitis suppurativa?
Dermatologists classify hidradenitis suppurativa into three severity tiers using the Hurley Staging System, established to guide medical and surgical intervention. The classification evaluates the presence of isolated nodules, the development of subcutaneous sinus tracts (draining tunnels), and the extent of confluent cicatricial scarring across the affected anatomical region.
The Hurley staging framework determines whether a patient can be successfully managed with conservative prescription medical therapy alone or requires combined dermatological surgery:
| Hurley Stage | Clinical Presentation | Pathological Anatomy | Primary Treatment Strategy |
|---|---|---|---|
| Stage I (Mild) | Single or multiple isolated nodules and abscesses | No sinus tract tunnels; no fibrotic scarring | Topical clindamycin, oral tetracyclines, spironolactone |
| Stage II (Moderate) | Recurrent abscesses with separated lesions | Single or multiple sinus tracts; localized scarring | Oral antibiotics, biologic therapy, localized deroofing |
| Stage III (Severe) | Diffuse or broad continuous plaque involvement | Interconnected sinus tracts & confluent abscesses | Targeted biologics, combination antibiotics, wide surgical excision |
According to clinical epidemiology data from the Cleveland Clinic, approximately 68% of diagnosed patients present with Hurley Stage I, 28% with Hurley Stage II, and only 4% advance to severe Hurley Stage III disease.
Because progression between stages involves irreversible structural remodeling of the dermis, prompt intervention while lesions remain categorized as Stage I provides the highest likelihood of preserving skin integrity.
What is the best prescription treatment for hidradenitis suppurativa?
The most effective prescription treatment for hidradenitis suppurativa depends on the Hurley stage, targeting both acute inflammation and underlying immune dysregulation. Mild early cases are managed with topical clindamycin 1% and oral doxycycline, while cyclical female flares respond well to oral spironolactone. Moderate-to-severe disease requires targeted biologic therapies like adalimumab or secukinumab.
Because HS is driven by autoinflammatory cascades rather than an active bacterial infection, dermatologists prescribe antibiotics primarily for their anti-inflammatory and immunomodulating properties rather than antimicrobial eradication:
1. Topical Antibacterial Therapy (Clindamycin 1%)
For Hurley Stage I disease characterized by superficial nodules, dermatologists prescribe topical clindamycin 1% lotion or gel applied twice daily. Topical clindamycin calms localized follicular erythema and decreases bacterial colonization that can secondary-infect open lesions.
To prevent bacterial resistance, clinicians frequently advise pairing topical clindamycin with an antiseptic wash like chlorhexidine or benzoyl peroxide. For detailed safety and administration guidance, explore our clindamycin for acne guide.
2. Oral Tetracyclines (Doxycycline)
When topical therapies prove insufficient or multiple body areas are involved, oral doxycycline (100 mg twice daily) is prescribed for 10 to 12 weeks. Doxycycline inhibits matrix metalloproteinases (MMPs) and curbs neutrophil chemotaxis, reducing deep tissue swelling.
In a prospective European multicenter cohort study published in the Journal of the American Academy of Dermatology by van der Zee et al. (PMID: 33484733), 12 weeks of oral tetracycline therapy produced a statistically significant reduction in inflammatory lesion counts and International HS Severity Scores, demonstrating high efficacy for stabilizing mild-to-moderate flares.
3. Antiandrogen Therapy (Oral Spironolactone)
For female patients who notice flare-ups aligning with menstrual cycles or have concurrent conditions like polycystic ovary syndrome (PCOS), dermatologists prescribe oral spironolactone (50 mg to 100 mg daily). Spironolactone competitively blocks androgen receptors on sebaceous glands, reducing follicular hyperkeratinization.
In a clinical study published in the Journal of the American Academy of Dermatology by Golbari et al. (PMID: 30003993), female HS patients treated with spironolactone demonstrated statistically significant reductions in pain scores (P = .01), inflammatory lesion counts (P = .02), and Physician’s Global Assessment scores (P < .001). Learn more about oral dosing in our spironolactone for acne guide.
4. Targeted Biologics (Adalimumab & Secukinumab)
For moderate-to-severe disease (Hurley Stage II and III) that resists oral antibiotics, targeted injectable biologics represent standard medical therapy. Adalimumab (Humira), a monoclonal antibody inhibiting tumor necrosis factor-alpha (TNF-alpha), and secukinumab (Cosentyx), an interleukin-17A (IL-17A) inhibitor, are FDA-approved to suppress systemic inflammatory cascades and reduce active nodule counts.
Can you get prescription hidradenitis suppurativa treatment online?
Yes, patients can obtain initial clinical evaluations and prescription therapies for mild-to-moderate hidradenitis suppurativa through teledermatology platforms. Board-certified dermatologists and licensed clinicians examine high-resolution photographs, assess Hurley staging, and prescribe topical clindamycin, oral doxycycline, or spironolactone. However, severe disease involving draining sinus tracts requires in-person surgical intervention.
Teledermatology offers an accessible pathway to bypass lengthy multi-month waits for in-office specialist visits, helping patients initiate evidence-based medical care early in Hurley Stage I.
Understanding how telehealth works helps simplify your virtual intake. Below is how top telehealth providers compare for managing early-stage follicular flares:
| Provider | Available Treatments | Consultation Model | Estimated Pricing |
|---|---|---|---|
| Nurx | Topical Clindamycin 1%, Oral Doxycycline, Oral Spironolactone | Asynchronous photo and medical history intake | ~$40 consultation + $15–$30/month medication |
| Ro Derm | Oral Doxycycline, Oral Spironolactone, custom topical formulas | Asynchronous digital clinical intake | ~$30 consultation + $30–$40/month medication |
| Hers | Oral Spironolactone (for hormonal flare management) | Asynchronous medical questionnaire review | Starting at ~$35/month |
| Honeydew Care | Topical Clindamycin, Doxycycline, Spironolactone, Biologics | Asynchronous messaging and video visits | ~$40/month membership (insurance accepted) |
- Nurx: Provides rapid asynchronous assessments where licensed clinicians evaluate inflammatory bumps and prescribe topical clindamycin or oral antibiotics delivered directly to your door (Nurx).
- Ro Derm: Offers customized prescription care with dedicated clinical follow-ups, managing oral anti-inflammatories and hormonal treatments (Ro Derm).
- Hers: Specializes in women’s hormonal telehealth, offering oral spironolactone prescriptions for adult women with androgen-linked skin flares starting at $35 per month (Hers).
Clinical Note: While virtual dermatology is ideal for medical management of Hurley Stage I disease, patients exhibiting persistent draining tunnels, non-healing open wounds, or severe chronic pain should seek in-person evaluation with an experienced dermatologist or surgeon for procedural unroofing or deroofing.
Frequently asked questions
What is the difference between hidradenitis suppurativa and boils? Boils (furuncles) are isolated, acute bacterial infections of single hair follicles that drain, heal, and rarely recur in identical locations. In contrast, hidradenitis suppurativa is a chronic, non-infectious inflammatory disease causing recurrent deep nodules, interconnecting sinus tracts (tunnels), and permanent rope-like scarring in intertriginous skin folds.
What causes hidradenitis suppurativa flare-ups? Hidradenitis suppurativa flares are triggered by follicular hyperkeratosis, mechanical friction, and dysregulated immune signaling driven by pro-inflammatory cytokines like TNF-alpha and IL-17. Secondary triggers that exacerbate flares include hormonal fluctuations during menstrual cycles, chronic emotional stress, elevated humidity and perspiration, nicotine use, and metabolic syndrome.
What are the three stages of hidradenitis suppurativa? Hidradenitis suppurativa is clinically categorized using the Hurley Staging System: Stage I consists of single or isolated abscesses without sinus tract tunnels or scarring; Stage II features recurrent abscesses with separated lesions, tunnel formation, and localized scars; and Stage III involves diffuse, confluent plaques with widespread interconnected tunnels across an entire region.
What is the best prescription treatment for hidradenitis suppurativa? Treatment depends on Hurley stage and inflammatory severity. Mild Stage I disease responds to topical clindamycin 1% and oral doxycycline (100 mg twice daily). For female patients with cyclical flares, dermatologists frequently prescribe spironolactone. Moderate-to-severe disease (Hurley Stage II or III) requires targeted systemic biologics, such as adalimumab or secukinumab.
Can hidradenitis suppurativa be cured permanently? No, hidradenitis suppurativa cannot be cured permanently because it is a lifelong systemic inflammatory condition. However, modern prescription treatments, anti-inflammatory medications, and targeted biologics can effectively halt disease progression, suppress active flare-ups, relieve severe pain, and maintain long-term clinical remission.
Can you get prescription hidradenitis suppurativa treatment online? Yes, asynchronous teledermatology services evaluate early hidradenitis suppurativa online. Licensed medical providers examine clinical photographs and medical histories, diagnose follicular lesions, and electronically prescribe topical clindamycin, oral tetracyclines, or spironolactone. Advanced disease with drainage tunnels typically requires in-person surgical unroofing or in-clinic biologic monitoring.
Bottom line
Hidradenitis suppurativa is a serious, painful, but medically manageable inflammatory condition that requires timely dermatological care. Because early Stage I lesions are frequently confused with standard ingrown hairs or minor boils, seeking clinical evaluation early is the single most effective way to prevent permanent tissue scarring and subcutaneous tunneling.
Modern targeted prescription therapies—from topical clindamycin and oral doxycycline to spironolactone and systemic biologics—enable patients to regain control over flare cycles and achieve lasting skin comfort.
Consult with Nurx for prescription topicals · Explore Hers for hormonal therapies · Consult with Ro Derm
To learn more about related follicular conditions and prescription treatment strategies, read our guides to acne treatment options, fungal folliculitis, topical clindamycin, and spironolactone for hormonal flares. You can also compare comprehensive telehealth reviews in our Nurx review and Hers review.
Sources: PMID 38572195 · PMID 37696341 · PMID 33484733 · PMID 30003993 · Cleveland Clinic: Hidradenitis Suppurativa